Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrew Wirth. (2011) Primary central nervous system lymphoma: the challenge continues. Leukemia & Lymphoma 52:11, pages 2037-2038.
Read now
Read now
Articles from other publishers (20)
Junya Yamaguchi, Fumiharu Ohka, Chalise Lushun, Kazuya Motomura, Kosuke Aoki, Kazuhito Takeuchi, Yuichi Nagata, Satoshi Ito, Nobuhiko Mizutani, Masasuke Ohno, Noriyuki Suzaki, Syuntaro Takasu, Yukio Seki, Takahisa Kano, Kenichi Wakabayashi, Hirofumi Oyama, Shingo Kurahashi, Kuniaki Tanahashi, Masaki Hirano, Hiroyuki Shimizu, Yotaro Kitano, Sachi Maeda, Shintaro Yamazaki, Toshihiko Wakabayashi, Yutaka Kondo, Atsushi Natsume & Ryuta Saito. (2022)
CD79B
Y196
mutation is a potent predictive marker for favorable response to
R‐MPV
in primary central nervous system lymphoma
. Cancer Medicine 12:6, pages 7116-7126.
Crossref
Crossref
I.V. Cherkashina, M.A. Vernyuk, A.M. Chervontseva, E.E. Gushchina, L.S. Khairullina & A.A. Fedenko. (2022) Modern aspects of the diagnosis and treatment of primary central nervous system lymphomas. Onkologiya. Zhurnal imeni P.A.Gertsena 11:6, pages 49.
Crossref
Crossref
Christopher P. Fox, Ayesha S. AliGraham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. JacksonLouise M. HopkinsCatherine M. ThomasShireen KassamJosh WrightSridhar ChagantiJeffery SmithIan ChauDominic CulliganKim M. Linton, Graham P. CollinsAndrés J. M. Ferreri, David LewisAndrew J. DaviesRod JohnsonDorothee P. Auer & Kate Cwynarski. (2021) A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial. Blood Advances 5:20, pages 4073-4082.
Crossref
Crossref
I. V. Cherkashina, M. A. Vernyuk, A. M. Chervontseva, E. E. Gushchina, L. S. Khayrullina, V. V. Lunin, P. A. Zeynalova & A. A. Fedenko. (2021) Treatment of primary central nervous system lymphomas. Oncohematology 16:2, pages 10-20.
Crossref
Crossref
Nobuyoshi Sasaki, Keiichi Kobayashi, Kuniaki Saito, Saki Shimizu, Kaori Suzuki, Jeunghun Lee, Yuki Yamagishi, Junji Shibahara, Nobuyuki Takayama, Yoshiaki Shiokawa & Motoo Nagane. (2020) Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy. Japanese Journal of Clinical Oncology 50:9, pages 999-1008.
Crossref
Crossref
Shoichi Deguchi, Kazuaki Nakashima, Koji Muramatsu, Koichi Mitsuya, Takuma Oishi, Kensei Shirata, Nakamasa Hayashi, Takashi Sugino, Masahiro Endo & Yoko Nakasu. (2019) Pretreatment intratumoral susceptibility signals correlate with response to high-dose methotrexate and progression-free survival in primary central nervous system lymphoma. Journal of Clinical Neuroscience 69, pages 43-50.
Crossref
Crossref
Christopher P. Fox, Elizabeth H. Phillips, Jeffery Smith, Kim Linton, Eve Gallop-Evans, Claire Hemmaway, Dorothee P. Auer, Charlotte Fuller, Andrew J. Davies, Pamela McKay & Kate Cwynarski. (2019) Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. British Journal of Haematology 184:3, pages 348-363.
Crossref
Crossref
Louis Royer-Perron & Khê Hoang-Xuan. (2018) Management of primary central nervous system lymphoma. La Presse Médicale 47:11-12, pages e213-e244.
Crossref
Crossref
Lushun Chalise, Fumiharu Ohka, Masaki Hirano, Kuniaki Tanahashi & Toshihiko Wakabayashi. (2018) Treatment of Primary CNS Lymphoma with RMPV (Rituximab, Methotrexate, Procarbazine, Vincristine) Therapy : Challenges and Prospects. Japanese Journal of Neurosurgery 27:1, pages 29-36.
Crossref
Crossref
B Kasenda, G Ihorst, R Schroers, A Korfel, I Schmidt-Wolf, G Egerer, L von Baumgarten, A Röth, J Bloehdorn, R Möhle, M Binder, U Keller, M Lamprecht, M Pfreundschuh, E Valk, H Fricker, E Schorb, K Fritsch, J Finke & G Illerhaus. (2017) High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia 31:12, pages 2623-2629.
Crossref
Crossref
Tim Strüßmann, Kristina Fritsch, Axel Baumgarten, Thomas Fietz, Monika Engelhardt, Roland Mertelsmann, Gabriele Ihorst, Justus Duyster, Jürgen Finke & Reinhard Marks. (2017) Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation. British Journal of Haematology 178:6, pages 927-935.
Crossref
Crossref
Semra Paydas. (2017) Primary central nervous system lymphoma: essential points in diagnosis and management. Medical Oncology 34:4.
Crossref
Crossref
Elisabeth Schorb, Juergen Finke, Andrés J. M. Ferreri, Gabriele Ihorst, Kristina Mikesch, Benjamin Kasenda, Kristina Fritsch, Heidi Fricker, Elvira Burger, Olga Grishina, Elke Valk, Emanuele Zucca & Gerald Illerhaus. (2016) High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix). BMC Cancer 16:1.
Crossref
Crossref
Gerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst, Gerlinde Egerer, Monika Lamprecht, Ulrich Keller, Hans-Heinrich Wolf, Carsten Hirt, Stephan Stilgenbauer, Mascha Binder, Peter Hau, Matthias Edinger, Norbert Frickhofen, Martin Bentz, Robert Möhle, Alexander Röth, Michael Pfreundschuh, Louisa von Baumgarten, Martina Deckert, Claudia Hader, Heidi Fricker, Elke Valk, Elisabeth Schorb, Kristina Fritsch & Jürgen Finke. (2016) High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. The Lancet Haematology 3:8, pages e388-e397.
Crossref
Crossref
A. Korfel & U. Schlegel. (2015) Prim?re ZNS-LymphomePrimary CNS lymphoma. Der Nervenarzt 86:6, pages 710-715.
Crossref
Crossref
Moon Ki Choi, Eun Suk Kang, Dae Won Kim, Yonug Hyeh Ko, Hyeri Seok, Jin Hong Park, Dae Hee Pyo, Do Hoon Lim, Seok Jin Kim & Won Seog Kim. (2013) Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation. International Journal of Hematology 98:3, pages 346-354.
Crossref
Crossref
Silvia Mappa, Emerenziana Marturano, Giada Licata, Maurizio Frezzato, Niccolò Frungillo, Fiorella Ilariucci, Caterina Stelitano, Antonella Ferrari, Mariella Sorarù, Fabrizio Vianello, Luca Baldini, Ilaria Proserpio, Marco Foppoli, Andrea Assanelli, Michele Reni, Federico Caligaris‐Cappio & Andrés J. M. Ferreri. (2012) Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R‐IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high‐dose methotrexate‐based chemotherapy. Hematological Oncology 31:3, pages 143-150.
Crossref
Crossref
Xinchong Shi, Xiangsong Zhang, Chang Yi, Xiaoyan Wang, Zhifeng Chen & Bing Zhang. (2013) The Combination of 13N-Ammonia and 18F-FDG in Predicting Primary Central Nervous System Lymphomas in Immunocompetent Patients. Clinical Nuclear Medicine 38:2, pages 98-102.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:6, pages 756-768.
Crossref
Crossref
Prathima ProdduturiPhilip J Bierman. (2012) Current and Emerging Pharmacotherapies for Primary CNS Lymphoma. Clinical Medicine Insights: Oncology 6, pages CMO.S7752.
Crossref
Crossref